Navigation Links
Shareholder Letter from Chairman of China Sky One Medical
Date:1/21/2011

HARBIN, China, Jan. 21, 2011 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company in the People's Republic of China ("PRC"), today announced the shareholder letter from Mr. Yanqing Liu, the Company's Chairman of Board of Directors, and Chief Executive Officer. The full text of this shareholder letter is as follows:

Dear Shareholders,

Our company's reputation continues to be tarnished by unfounded allegations of certain self-serving investors, whose viewpoints recently have been rehashed in media outlets, driving our share price down and create panic among our valued shareholders.

We regret that our faithful shareholders have suffered loss in the capital market as a result of reckless criticism and attacks. Most of the issues that recently resurfaced in the media were raised some time ago and have already been addressed by management. We have worked closely and diligently with all SEC inquiries and will continue to do so.

As you know, despite all attempts, China Sky One Medical is one of China's leading pharmaceutical companies. We manufacture and distribute over 100 products across approximately 30,000 pharmacies and 1,000 hospitals throughout China. We will continue to focus on delivering strong operating performance, which should provide a key source of confidence for our shareholders in the long run. So far, there are not many shareholders who have been visiting the Company, or met with our management team. Without conducting field research or seeing firsthand the dedication of our professionals, we consider the negative challenges have demonstrated little interest in knowing the business.

China Sky One Medical operates four pharmaceutical factories and two R&D centers in China. We are well positioned in the country's pharmaceutical industry, with strong R&D capabilities and expanding marketing and branding strategies. The Company has a world-class product pipeline, which represents huge business potential. Based on China Sky One's fundamentals, the management is optimistic for a brighter future.

In the Company's history, our executive directors have never sold a single share of China Sky One Medical. Despite all the accusations, we will keep focusing on business development and continue to focus on managing our business to create long term shareholder value. We also intend to continue to update investors regularly through press releases as we reach any key milestones in 2011, including research and development progress, as well as new business advances. We highly value smooth and transparent communication with our investors.

Management is now busy working on annual auditing and reporting for 2010. As soon as practical, we intend to update investors on our 2010 performance and our financial guidance for 2011.

To provide foreign investors a better opportunity to understand the real China Sky One Medical, especially at this critical time, we want to extend a sincere open invitation to our current shareholders, potential investors, and different opinion holders to visit our headquarters and pharmacies in China. We will show you how we manage the business from manufacturing to distributing. We are willing to cover your travel expenses in China. "Seeing is the base of believing." China Sky One Medical truly welcomes investors and media to come visiting us and understand how we conduct our business with their own eyes!

Mr. Yanqing Liu

Chairman of Board of Directors, and Chief Executive Officer

China Sky One Medical

(End of the shareholder letter)

About China Sky One Medical, Inc. China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company, Harbin First Bio-Engineering Company Limited, Heilongjiang Tianlong Pharmaceutical, Inc. and Peng Lai Jin Chuang Pharmaceutical Company, the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.cski.com.cn.

Safe Harbor Statement

Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding the Company's product pipeline, sales and marketing as well as other financial or operational information. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.Investor Relations Contact:China Sky One Medical

CCG Investor Relations Yanqing Liu, CEO

Crocker Coulson, President  Email: ir@cski.com.cn

Tel: +1-646-213-1915Email: crocker.coulson@ccgir.comWebsite: www.ccgirasia.com Mabel Zhang, Vice President Tel: +1-310-954-1353Email: mabel.zhang@ccgir.com
'/>"/>

SOURCE China Sky One Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Tianyin Pharmaceutical to Hold 2010 Shareholder Annual Meeting on March 21, 2011 at NYSE
2. BD Announces Webcast of Annual Meeting of Shareholders
3. Advanced Life Sciences to Explore Strategic Alternatives to Maximize Shareholder Value
4. Mindray Medical Announces Shareholder Resolutions Adopted at 2010 Annual General Meeting
5. Hanger Orthopedic Group, Inc. Announces Pricing of Underwritten Public Offering by Shareholder
6. K-V Pharmaceutical Company Announces Reliance on Financial Distress Exception to NYSEs Shareholder Approval Policy
7. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2010 Annual General Meeting
8. Penwest Pharmaceuticals Shareholders Approve Merger With Subsidiary of Endo Pharmaceuticals
9. Cannabis Science Announces a Proposed 10:1 Ratio Structured Dividend Payout for a New Class of Common Shares to Shareholders of Record as of November 30, 2010
10. Adeona to Hold Annual Shareholder Meeting
11. China Sky One Medical, Inc. Reports Outcome of Annual Meeting of Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  According to the Centers for Disease Control and Prevention ... . PhysicianOne Urgent Care is helping communities across Massachusetts ... , by offering no-cost* flu shots through the end of the month. ... health insurance regulations. ... to get a flu shot is by the end of October, according ...
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the ... analysis system called the HORIZON at MIBio 2017 in ... subvisible and visible particulate matter in biopharmaceutical samples with unprecedented speed ... of the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... viewers the lowdown on sciatica in a new episode of "Success Files," which ... current events and innovation and investigates each subject in-depth with passion and integrity. ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance ... management, will showcase a range of technology and learning solutions at the 68th ... and Expo to be held October 14–18, 2017 at the Mandalay Bay Resort ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... has recently contributed a medical article to the newly revamped Cosmetic Town ... article spotlights the hair transplant procedure known as Follicular Unit Extraction ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
Breaking Medicine News(10 mins):